Shiseido Venture Partners

Shiseido Venture Partners (SVP) is the corporate venture capital arm of Shiseido Company, the Japanese beauty and personal-care multinational, headquartered in Tokyo. Established in April 2016 as a wholly-owned investment vehicle within Shiseido's Open Innovation program, SVP was given an aggregate investment ceiling of JPY 3 billion (approximately $20 million at 2016 exchange rates) to back ventures at the intersection of beauty, wellness, and consumer technology. The mandate is thematic: technologies that create beauty, ideas that communicate beauty, and new business structures that deliver beauty to consumers. SVP leads rounds and deploys at seed through Series B, with checks up to $8 million. The fund's strategic value extends beyond capital — it offers portfolio companies access to Shiseido's global research capabilities, distribution channels, and brand relationships across the beauty industry. Notable investments include FiNC Technologies, the Japanese preventive-healthcare and fitness app backed in 2018, Awesome Woman, and most prominently Apothekary, the US herbal-wellness brand sold at Ulta Beauty, where SVP led an $8 million Seed II round in November 2024. The portfolio spans healthtech and wellness, consumer goods, and e-commerce across Japan, Asia, and the US. In December 2023 Shiseido launched a complementary vehicle, LIFT Ventures, a New York-based early-stage beauty and wellness fund led by Ron Gee, to add a dedicated US and global early-stage layer alongside SVP's Tokyo-based strategic activity. Together, the two vehicles give Shiseido a full-spectrum corporate innovation platform from seed through growth.